trending Market Intelligence /marketintelligence/en/news-insights/trending/QGt_LsY9yJqDCRCjcQOegw2 content esgSubNav
In This List

Acer Therapeutics appoints chief medical officer

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Acer Therapeutics appoints chief medical officer

Acer Therapeutics Inc., which has merged with Opexa Therapeutics Inc., appointed William Andrews as chief medical officer to replace Robert Steiner.

Previously, Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals Inc., Santhera Pharmaceuticals Holding AG, Sepracor, and ClinQuest.